3-50318299-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003773.5(HYAL2):​c.1252A>C​(p.Ile418Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0433 in 1,613,504 control chromosomes in the GnomAD database, including 13,055 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 2295 hom., cov: 32)
Exomes 𝑓: 0.037 ( 10760 hom. )

Consequence

HYAL2
NM_003773.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.344

Publications

12 publications found
Variant links:
Genes affected
HYAL2 (HGNC:5321): (hyaluronidase 2) This gene encodes a weak acid-active hyaluronidase. The encoded protein is similar in structure to other more active hyaluronidases. Hyaluronidases degrade hyaluronan, one of the major glycosaminoglycans of the extracellular matrix. Hyaluronan and fragments of hyaluronan are thought to be involved in cell proliferation, migration and differentiation. Although it was previously thought to be a lysosomal hyaluronidase that is active at a pH below 4, the encoded protein is likely a GPI-anchored cell surface protein. This hyaluronidase serves as a receptor for the oncogenic virus Jaagsiekte sheep retrovirus. The gene is one of several related genes in a region of chromosome 3p21.3 associated with tumor suppression. This gene encodes two alternatively spliced transcript variants which differ only in the 5' UTR.[provided by RefSeq, Mar 2010]
HYAL2 Gene-Disease associations (from GenCC):
  • orofacial cleft
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.2889481E-5).
BP6
Variant 3-50318299-T-G is Benign according to our data. Variant chr3-50318299-T-G is described in ClinVar as Benign. ClinVar VariationId is 1229880.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.581 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HYAL2NM_003773.5 linkc.1252A>C p.Ile418Leu missense_variant Exon 4 of 4 ENST00000357750.9 NP_003764.3
HYAL2NM_033158.5 linkc.1252A>C p.Ile418Leu missense_variant Exon 5 of 5 NP_149348.2
HYAL2XM_005265524.3 linkc.1252A>C p.Ile418Leu missense_variant Exon 5 of 5 XP_005265581.1
HYAL2XM_005265525.3 linkc.1252A>C p.Ile418Leu missense_variant Exon 4 of 4 XP_005265582.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HYAL2ENST00000357750.9 linkc.1252A>C p.Ile418Leu missense_variant Exon 4 of 4 1 NM_003773.5 ENSP00000350387.4
HYAL2ENST00000395139.7 linkc.1252A>C p.Ile418Leu missense_variant Exon 4 of 4 1 ENSP00000378571.3
HYAL2ENST00000447092.5 linkc.1252A>C p.Ile418Leu missense_variant Exon 3 of 3 1 ENSP00000401853.1
HYAL2ENST00000442581.1 linkc.1252A>C p.Ile418Leu missense_variant Exon 5 of 5 2 ENSP00000406657.1

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15854
AN:
152196
Hom.:
2293
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.184
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.266
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.599
Gnomad SAS
AF:
0.0211
Gnomad FIN
AF:
0.0468
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00362
Gnomad OTH
AF:
0.0876
GnomAD2 exomes
AF:
0.121
AC:
30469
AN:
250792
AF XY:
0.0988
show subpopulations
Gnomad AFR exome
AF:
0.179
Gnomad AMR exome
AF:
0.411
Gnomad ASJ exome
AF:
0.00328
Gnomad EAS exome
AF:
0.613
Gnomad FIN exome
AF:
0.0446
Gnomad NFE exome
AF:
0.00353
Gnomad OTH exome
AF:
0.0677
GnomAD4 exome
AF:
0.0369
AC:
53907
AN:
1461190
Hom.:
10760
Cov.:
31
AF XY:
0.0334
AC XY:
24282
AN XY:
726914
show subpopulations
African (AFR)
AF:
0.196
AC:
6550
AN:
33480
American (AMR)
AF:
0.389
AC:
17404
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00421
AC:
110
AN:
26132
East Asian (EAS)
AF:
0.535
AC:
21226
AN:
39700
South Asian (SAS)
AF:
0.0102
AC:
883
AN:
86258
European-Finnish (FIN)
AF:
0.0441
AC:
2324
AN:
52748
Middle Eastern (MID)
AF:
0.00728
AC:
42
AN:
5768
European-Non Finnish (NFE)
AF:
0.00174
AC:
1938
AN:
1111996
Other (OTH)
AF:
0.0568
AC:
3430
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
2158
4316
6474
8632
10790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
710
1420
2130
2840
3550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15882
AN:
152314
Hom.:
2295
Cov.:
32
AF XY:
0.111
AC XY:
8253
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.184
AC:
7653
AN:
41552
American (AMR)
AF:
0.267
AC:
4080
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3472
East Asian (EAS)
AF:
0.599
AC:
3100
AN:
5176
South Asian (SAS)
AF:
0.0209
AC:
101
AN:
4834
European-Finnish (FIN)
AF:
0.0468
AC:
498
AN:
10632
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00362
AC:
246
AN:
68024
Other (OTH)
AF:
0.0881
AC:
186
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
615
1230
1846
2461
3076
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0428
Hom.:
1356
Bravo
AF:
0.130
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.174
AC:
768
ESP6500EA
AF:
0.00535
AC:
46
ExAC
AF:
0.107
AC:
12961
Asia WGS
AF:
0.204
AC:
709
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
15
DANN
Benign
0.66
DEOGEN2
Benign
0.21
T;T;T;T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.0
.;.;.;T
MetaRNN
Benign
0.000013
T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-1.1
N;N;N;N
PhyloP100
0.34
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.090
N;N;N;N
REVEL
Benign
0.096
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
0.87
T;T;T;T
Vest4
0.034
ClinPred
0.0018
T
GERP RS
5.2
Varity_R
0.062
gMVP
0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35455589; hg19: chr3-50355730; COSMIC: COSV63306748; COSMIC: COSV63306748; API